| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/27/2001 | US20010055566 Method for viewing tumor tissue located within a body cavity |
| 12/27/2001 | US20010055565 Method of detecting cyclooxygenase-2 |
| 12/27/2001 | CA2414015A1 Human receptors |
| 12/27/2001 | CA2411971A1 Proteases |
| 12/26/2001 | CN1328472A Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 12/26/2001 | CN1328471A Near infrared fluorescent contrast agent and fluorescence imaging |
| 12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 12/25/2001 | US6333971 Fiducial marker |
| 12/25/2001 | US6333447 Transgenic model of heart failure |
| 12/25/2001 | US6333110 For visualization of soft tissue, medical imaging, contrast agents, diagnostic agents |
| 12/25/2001 | US6333021 For delivery of therapeutically and/or diagnostically active substance, when in suspension in physiologically acceptable carrier useful as delivery vehicles for therapeutically active agents and/or as contrast agents for echographic imaging |
| 12/25/2001 | US6333020 Methods for treating AVM's using radio active compositions |
| 12/20/2001 | WO2001096895A1 Method for investigating the fate of a test compound or the stateof a biological system by means of nmr of hyperpolarised nmr active nuclei |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096528A2 Human tumor necrosis factor delta and epsilon |
| 12/20/2001 | WO2001095947A1 Method for assessing cortical response to blue light |
| 12/20/2001 | WO2001095795A2 Optical imaging of induced signals in vivo under ambient light conditions |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001052835A3 Free radical scavengers for the treatment of premature birth |
| 12/20/2001 | WO2001024833A3 In vivo assay for testing the phenotypic stability |
| 12/20/2001 | WO2001017566A3 L-selectin contrast agents |
| 12/20/2001 | WO1999013916A3 Methods and compositions for medical imaging |
| 12/20/2001 | US20010053348 Method for testing sunscreens |
| 12/20/2001 | CA2413160A1 Human tumor necrosis factor delta and epsilon |
| 12/20/2001 | CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/19/2001 | EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 12/19/2001 | EP1163514A1 AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE |
| 12/19/2001 | EP1163239A1 Modified amino-acid amides as cgrp antagonists |
| 12/19/2001 | EP1163231A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics |
| 12/19/2001 | EP1163012A1 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| 12/19/2001 | EP1162963A1 Means for diagnosing and treating carcinoma |
| 12/19/2001 | EP0750649B1 Branched polyoxaalkyl macromolecules, process for making them and their uses |
| 12/19/2001 | EP0670695B1 Polymers as contrast media for magnetic resonance imaging |
| 12/19/2001 | EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 12/19/2001 | EP0437488B2 Animal model for human disease |
| 12/19/2001 | CN1326788A Supersonic development agent for gastrointestinal tract and its preparing method |
| 12/19/2001 | CN1076205C Particles for NMR imaging and method of manufacture |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331289 Targeted diagnostic/therapeutic agents having more than one different vectors |
| 12/18/2001 | US6331286 Methods for high energy phototherapeutics |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/13/2001 | WO2001094587A2 Extracellular messengers |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001093917A2 Preparation for breast duct fluid collection |
| 12/13/2001 | WO2001093916A1 Purification of functionalized fluorescent nanocrystals |
| 12/13/2001 | WO2001093915A1 Diagnosing colic type in an infant |
| 12/13/2001 | WO2001032184A3 Abc1 modulation for the modulation of cholesterol transport |
| 12/13/2001 | WO2001032139A3 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 12/13/2001 | US20010051743 Such as methyl ester; more effective than free form at slowing tumor growth |
| 12/13/2001 | US20010051132 Hyperpolarized helium-3 microbubble gas entrapment methods and associated products |
| 12/13/2001 | US20010051131 Administering acoustically active materials; applying ultrasonic frequencies |
| 12/13/2001 | DE3448606C2 Diagnostische Mittel, Verfahren zu deren Herstellung und deren Verwendung Diagnostic agents, to processes for their preparation and their use |
| 12/13/2001 | DE10024069A1 Konjugat auf der Basis einer heterobifunktionalen Brückenverbindung, die mit einem Immunmodulator und einer zellerkennenden Einheit substituiert ist Conjugate on the basis of a heterobifunctional bridge connection, which is substituted with an immunomodulator and a cell recognizing unit |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161265A1 Method for the identification and removal of nits from hair |
| 12/12/2001 | EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 12/12/2001 | EP0843560B1 Cellulose diacetate compositions for use in embolizing blood vessels |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326330A Therapeutic use of polymers |
| 12/12/2001 | CN1075951C Contrasting agents for near infrared diagnosis contg. colloidal systems loaded with polymethine dyes |
| 12/11/2001 | US6329566 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/11/2001 | US6329531 For therapy of alzheimer's disease |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001015628A3 In vivo screening methods for predicting calcification of implantable prosthetic material |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2410436A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/05/2001 | EP1160018A2 Method and apparatus for fine particle formation |
| 12/05/2001 | EP1039834A4 Optoacoustic contrast agents and methods for their use |
| 12/05/2001 | EP0754032B1 Liquid delivery compositions |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 12/05/2001 | CN1325286A Manganese compositions and methods for MRI |
| 12/05/2001 | CN1325284A Method for improved imaging and photodynamic therapy |
| 12/05/2001 | CN1075737C Method for the provocation of air passage narrowing and/or the induction of sputum |
| 12/04/2001 | US6325475 Devices for presenting airborne materials to the nose |
| 11/29/2001 | WO2001090359A2 G-protein coupled receptors |
| 11/29/2001 | WO2001090330A2 AMINOACYL tRNA SYNTHETASES |
| 11/29/2001 | WO2001090114A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
| 11/29/2001 | WO2001089586A2 Tc and re carbonyl complexes for pertechnetate and perrhenate |
| 11/29/2001 | WO2001089585A1 tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES |
| 11/29/2001 | WO2001089584A2 Contrast agents |
| 11/29/2001 | WO2001089576A2 Preparation hypericin bonded with poly-n-vinylamides |
| 11/29/2001 | WO2001089522A1 Compositions and methods for administration of pharmacologically active compounds |
| 11/29/2001 | WO2001089455A2 System and method for assessing the performance of a pharmaceutical agent delivery system |
| 11/29/2001 | WO2001089380A2 Combined impedance imaging and mammography |
| 11/29/2001 | WO2001089379A1 Apparatus for impedance imaging coupled with another modality |
| 11/29/2001 | WO2000066180A3 Method for enhancing contrast produced by mri |
| 11/29/2001 | US20010046983 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 11/29/2001 | US20010046502 Evaluating an antitumor response to a tumor (cancer) immunotherapy (hepten-modified tumor cell) administered to a mouse harboring a tumor |